HK1199617A1 - 用於治療病毒性疾病的組合物及方法 - Google Patents

用於治療病毒性疾病的組合物及方法

Info

Publication number
HK1199617A1
HK1199617A1 HK14113144.2A HK14113144A HK1199617A1 HK 1199617 A1 HK1199617 A1 HK 1199617A1 HK 14113144 A HK14113144 A HK 14113144A HK 1199617 A1 HK1199617 A1 HK 1199617A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
viral diseases
treating viral
treating
Prior art date
Application number
HK14113144.2A
Other languages
English (en)
Inventor
Eliezer Huberman
Original Assignee
Novadrug Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novadrug Llc filed Critical Novadrug Llc
Publication of HK1199617A1 publication Critical patent/HK1199617A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK14113144.2A 2011-08-24 2014-12-31 用於治療病毒性疾病的組合物及方法 HK1199617A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161526908P 2011-08-24 2011-08-24
PCT/US2012/052108 WO2013028890A1 (en) 2011-08-24 2012-08-23 Compositions and methods for treating viral diseases

Publications (1)

Publication Number Publication Date
HK1199617A1 true HK1199617A1 (zh) 2015-07-10

Family

ID=47746870

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14113144.2A HK1199617A1 (zh) 2011-08-24 2014-12-31 用於治療病毒性疾病的組合物及方法

Country Status (8)

Country Link
US (1) US9241930B2 (zh)
EP (1) EP2747765B1 (zh)
JP (1) JP6018206B2 (zh)
CN (1) CN103957911A (zh)
AU (1) AU2012298777B2 (zh)
CA (1) CA2846348C (zh)
HK (1) HK1199617A1 (zh)
WO (1) WO2013028890A1 (zh)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627165A (en) 1990-06-13 1997-05-06 Drug Innovation & Design, Inc. Phosphorous prodrugs and therapeutic delivery systems using same
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
WO2007124423A2 (en) 2006-04-21 2007-11-01 Smithkline Beecham Corporation Il-8 receptor antagonists
EP2094702B1 (en) 2006-12-14 2015-09-02 Gilead Sciences, Inc. Viral inhibitors
CN101619064B (zh) 2008-07-01 2011-05-11 韶远化学科技（上海）有限公司 多氮杂环医药中间体的合成及工艺方法
US20100029706A1 (en) * 2008-07-30 2010-02-04 Edison Parmaceuticals, Inc. a Delaware Corporation HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS
US20110195929A1 (en) * 2008-08-05 2011-08-11 Summit Corporation Plc Compounds for the treatment of flaviviral infections
WO2011109232A1 (en) 2010-03-01 2011-09-09 Novadrug, Llc Compositions and methods for treating viral diseases
WO2011116287A1 (en) 2010-03-19 2011-09-22 Purdue Research Foundation Ccr5 modulators for treating hiv

Also Published As

Publication number Publication date
EP2747765A1 (en) 2014-07-02
EP2747765B1 (en) 2016-08-10
US9241930B2 (en) 2016-01-26
AU2012298777B2 (en) 2016-11-03
JP6018206B2 (ja) 2016-11-02
AU2012298777A1 (en) 2014-04-03
JP2014529611A (ja) 2014-11-13
CA2846348C (en) 2019-01-22
EP2747765A4 (en) 2015-02-25
US20140249178A1 (en) 2014-09-04
WO2013028890A1 (en) 2013-02-28
CA2846348A1 (en) 2013-02-28
CN103957911A (zh) 2014-07-30

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
EP2684167A4 (en) COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF DISEASES
HK1202416A1 (zh) 預防及治療口腔疾病的組合物及方法
ZA201305783B (en) Composition and methods for treating cardiovascular diseases
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
SG11201402609RA (en) Compositions and methods for treating hepatitis c virus
EP2701742A4 (en) COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
EP2773342A4 (en) COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES
DK3292875T3 (en) Compositions and methods for treating diseases
EP2771341A4 (en) NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
ZA201404187B (en) Compositions and methods for treating dental conditions
EP2691529A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
HK1202248A1 (zh) 用於治療神經退行性疾病的組合物和方法
HK1202246A1 (zh) 用於治療神經退行性疾病的組合物和方法
EP2802353A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2663327A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2604264A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRUS DISEASES
ZA201207226B (en) Compositions and methods for treating viral diseases
SG11201402899TA (en) Methods and compositions for treating viral diseases
PT2838903T (pt) Métodos e composições para tratamento de infeções virais
HK1199617A1 (zh) 用於治療病毒性疾病的組合物及方法
EP2718427A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF GLIOBLASTOMES
IL232889A0 (en) Compounds and methods for treating hepatitis c virus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200819